XENE XENON PHARMACEUTICALS INC

Ownership history in First Turn Management, LLC  ·  9 quarters on record

This page tracks every 13F SEC filing in which First Turn Management, LLC reported a position in XENON PHARMACEUTICALS INC (XENE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
4.82% (2025 Q3)
Avg. % of fund
3.92%
First filed
2023 Q4
Last filed
2025 Q4
Quarters held
9
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 799,743 0% 4.10% $35.8M $44.82
2025 Q3 ADDED 799,743 +139,126 +21.1% 4.82% $32.1M $40.15
2025 Q2 REDUCED 660,617 -22,834 -3.3% 3.86% $20.7M $31.30
2025 Q1 REDUCED 683,451 -1,535 -0.2% 4.62% $22.9M $33.55
2024 Q4 ADDED 684,986 +359,768 +110.6% 4.81% $26.9M $39.20
2024 Q3 REDUCED 325,218 -14,658 -4.3% 2.03% $12.8M $39.37
2024 Q2 REDUCED 339,876 -340,513 -50.0% 2.16% $13.3M $38.99
2024 Q1 UNCHANGED 680,389 0% 4.38% $29.3M $43.05
2023 Q4 INITIATED 680,389 4.50% $31.3M
% of Fund (quarterly)    XENE price (monthly, adj. close)
← Back to First Turn Management, LLC Holdings